Succinylcholine, malignant hyperthermia and rhabdomyolysis

The pharmacogenetic disorder malignant hyperthermia is often mistakenly considered to fall solely within the purview of anesthesiology practice. Although this is generally accurate in the case of the potent volatile anesthetics, succinylcholine remains a muscle relaxant of choice for performing rapi...

Full description

Saved in:
Bibliographic Details
Published in:Canadian Medical Association journal (CMAJ) 2022-06, Vol.194 (25), p.E878-E878
Main Author: Blais, Alex
Format: Article
Language:English
Subjects:
Anesthesiology
Fever
Hyperthermia
Immunization
Letters
Rhabdomyolysis
Severe acute respiratory syndrome coronavirus 2
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c353t-35184cad87190fb8e2b091d32733a4df40198995d6eb91b291285f517160e7c43
cites
container_end_page E878
container_issue 25
container_start_page E878
container_title Canadian Medical Association journal (CMAJ)
container_volume 194
creator Blais, Alex
description The pharmacogenetic disorder malignant hyperthermia is often mistakenly considered to fall solely within the purview of anesthesiology practice. Although this is generally accurate in the case of the potent volatile anesthetics, succinylcholine remains a muscle relaxant of choice for performing rapid sequence tracheal intubation outside of the operating room. Here, Blais highlights Salter et al's case study of rhabdomyolysis possibly associated with mRNA SARS-CoV-2 vaccination.
doi_str_mv 10.1503/cmaj.146480-l
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9332916</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A708100310</galeid><sourcerecordid>A708100310</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-35184cad87190fb8e2b091d32733a4df40198995d6eb91b291285f517160e7c43</originalsourceid><addsrcrecordid>eNpdkUFr3DAQhUVIyG6THHNfKIQe6kQjybaUQyCEtgkEckh6FrIsr7XI0kayC_73Veql0M5lDvPxePMeQpeAr6HE9EYPancNrGIcF-4IrYFxXhBKxDFaY05wQQWrVuhTSjuch5L6FK1oWVeYkXqNbl8nra2fne6Ds9583QzK2a1Xftz0897EsTdxsGqjfLuJvWraMMzBzcmmc3TSKZfMxWGfoZ_fv709PBbPLz-eHu6fC01LOha0BM60ankNAncNN6TBAtpshFLF2o5hEFyIsq1MI6AhAggvuxJqqLCpNaNn6G7R3U_NYFpt_BiVk_toBxVnGZSV_1687eU2_JKC5higygJfDgIxvE8mjXKwSRvnlDdhSpJUHDiQitYZ_fwfugtT9Pm9P5TABChk6mqhtsoZ2Rvlxj4FN402-CTva8whJw04g8UC6hhSiqb76xqw_KhPftQnl_qko78BP0yLjg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2681902131</pqid></control><display><type>article</type><title>Succinylcholine, malignant hyperthermia and rhabdomyolysis</title><source>PubMed Central (Open access)</source><creator>Blais, Alex</creator><creatorcontrib>Blais, Alex</creatorcontrib><description>The pharmacogenetic disorder malignant hyperthermia is often mistakenly considered to fall solely within the purview of anesthesiology practice. Although this is generally accurate in the case of the potent volatile anesthetics, succinylcholine remains a muscle relaxant of choice for performing rapid sequence tracheal intubation outside of the operating room. Here, Blais highlights Salter et al's case study of rhabdomyolysis possibly associated with mRNA SARS-CoV-2 vaccination.</description><identifier>ISSN: 0820-3946</identifier><identifier>EISSN: 1488-2329</identifier><identifier>DOI: 10.1503/cmaj.146480-l</identifier><identifier>PMID: 35760427</identifier><language>eng</language><publisher>Ottawa: CMA Impact Inc</publisher><subject>Anesthesiology ; Fever ; Hyperthermia ; Immunization ; Letters ; Rhabdomyolysis ; Severe acute respiratory syndrome coronavirus 2</subject><ispartof>Canadian Medical Association journal (CMAJ), 2022-06, Vol.194 (25), p.E878-E878</ispartof><rights>COPYRIGHT 2022 CMA Impact Inc.</rights><rights>Copyright CMA Impact, Inc. Jun 27, 2022</rights><rights>2022 CMA Impact Inc. or its licensors 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-35184cad87190fb8e2b091d32733a4df40198995d6eb91b291285f517160e7c43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332916/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332916/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids></links><search><creatorcontrib>Blais, Alex</creatorcontrib><title>Succinylcholine, malignant hyperthermia and rhabdomyolysis</title><title>Canadian Medical Association journal (CMAJ)</title><description>The pharmacogenetic disorder malignant hyperthermia is often mistakenly considered to fall solely within the purview of anesthesiology practice. Although this is generally accurate in the case of the potent volatile anesthetics, succinylcholine remains a muscle relaxant of choice for performing rapid sequence tracheal intubation outside of the operating room. Here, Blais highlights Salter et al's case study of rhabdomyolysis possibly associated with mRNA SARS-CoV-2 vaccination.</description><subject>Anesthesiology</subject><subject>Fever</subject><subject>Hyperthermia</subject><subject>Immunization</subject><subject>Letters</subject><subject>Rhabdomyolysis</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><issn>0820-3946</issn><issn>1488-2329</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpdkUFr3DAQhUVIyG6THHNfKIQe6kQjybaUQyCEtgkEckh6FrIsr7XI0kayC_73Veql0M5lDvPxePMeQpeAr6HE9EYPancNrGIcF-4IrYFxXhBKxDFaY05wQQWrVuhTSjuch5L6FK1oWVeYkXqNbl8nra2fne6Ds9583QzK2a1Xftz0897EsTdxsGqjfLuJvWraMMzBzcmmc3TSKZfMxWGfoZ_fv709PBbPLz-eHu6fC01LOha0BM60ankNAncNN6TBAtpshFLF2o5hEFyIsq1MI6AhAggvuxJqqLCpNaNn6G7R3U_NYFpt_BiVk_toBxVnGZSV_1687eU2_JKC5higygJfDgIxvE8mjXKwSRvnlDdhSpJUHDiQitYZ_fwfugtT9Pm9P5TABChk6mqhtsoZ2Rvlxj4FN402-CTva8whJw04g8UC6hhSiqb76xqw_KhPftQnl_qko78BP0yLjg</recordid><startdate>20220627</startdate><enddate>20220627</enddate><creator>Blais, Alex</creator><general>CMA Impact Inc</general><general>CMA Impact, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M3G</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220627</creationdate><title>Succinylcholine, malignant hyperthermia and rhabdomyolysis</title><author>Blais, Alex</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-35184cad87190fb8e2b091d32733a4df40198995d6eb91b291285f517160e7c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anesthesiology</topic><topic>Fever</topic><topic>Hyperthermia</topic><topic>Immunization</topic><topic>Letters</topic><topic>Rhabdomyolysis</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blais, Alex</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business &amp; Current Affairs Database</collection><collection>Canadian Business &amp; Current Affairs Database (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>CBCA Reference &amp; Current Events</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian Medical Association journal (CMAJ)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blais, Alex</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Succinylcholine, malignant hyperthermia and rhabdomyolysis</atitle><jtitle>Canadian Medical Association journal (CMAJ)</jtitle><date>2022-06-27</date><risdate>2022</risdate><volume>194</volume><issue>25</issue><spage>E878</spage><epage>E878</epage><pages>E878-E878</pages><issn>0820-3946</issn><eissn>1488-2329</eissn><abstract>The pharmacogenetic disorder malignant hyperthermia is often mistakenly considered to fall solely within the purview of anesthesiology practice. Although this is generally accurate in the case of the potent volatile anesthetics, succinylcholine remains a muscle relaxant of choice for performing rapid sequence tracheal intubation outside of the operating room. Here, Blais highlights Salter et al's case study of rhabdomyolysis possibly associated with mRNA SARS-CoV-2 vaccination.</abstract><cop>Ottawa</cop><pub>CMA Impact Inc</pub><pmid>35760427</pmid><doi>10.1503/cmaj.146480-l</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0820-3946
ispartof Canadian Medical Association journal (CMAJ), 2022-06, Vol.194 (25), p.E878-E878
issn 0820-3946
1488-2329
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9332916
source PubMed Central (Open access)
subjects Anesthesiology
Fever
Hyperthermia
Immunization
Letters
Rhabdomyolysis
Severe acute respiratory syndrome coronavirus 2
title Succinylcholine, malignant hyperthermia and rhabdomyolysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T09%3A03%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Succinylcholine,%20malignant%20hyperthermia%20and%20rhabdomyolysis&rft.jtitle=Canadian%20Medical%20Association%20journal%20(CMAJ)&rft.au=Blais,%20Alex&rft.date=2022-06-27&rft.volume=194&rft.issue=25&rft.spage=E878&rft.epage=E878&rft.pages=E878-E878&rft.issn=0820-3946&rft.eissn=1488-2329&rft_id=info:doi/10.1503/cmaj.146480-l&rft_dat=%3Cgale_pubme%3EA708100310%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-35184cad87190fb8e2b091d32733a4df40198995d6eb91b291285f517160e7c43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2681902131&rft_id=info:pmid/35760427&rft_galeid=A708100310&rfr_iscdi=true